Under the plans, codenamed Project Spring, GSK will consider moving some of the desktop tasks overseas. Glaxo has 66,000 desktop units in Britain, for uses such as payroll and scientists' research work. The outside suppliers are expected to enter a formal tender process early in the New Year.